Pre Gestational Thalassemia Screening in Mainland China: The First Two Years of a Preventive Program

Abstract In this study, we report the experience of a pre gestational thalassemia screening program at a single center in Southern China. Free thalassemia screening, genetic counseling and prenatal diagnosis (PND) for couples planning pregnancy were implemented over a 2-year period. Among a total of 83,062 screened individuals (41,531 couples), the allele frequencies of β-thalassemia (β-thal), – –SEA and – –THAI deletions were 3.79, 5.75 and 0.028%, respectively. Out of the 41,531 couples, 11,039 couples had at least one partner who had a positive screening test; of these, 455 at-risk couples (1.07%) were identified, including 68 (0.16%) for β-thal, 162 (0.39%) for Hb Bart’s (γ4) hydrops fetalis, 190 (0.46%) for deletional Hb H (β4) disease and 25 (0.06%) for nondeletional Hb H disease. Of the 455 at-risk couples, 90 were already pregnant and 66 underwent PND at 10-13 weeks’ gestation, resulting in 15 affected fetuses. The remaining 355 at-risk couples were still preparing for pregnancy, and they were on the list for follow-up. There is considerable scope for facilitating timely PND through improved organization and screening strategy. The pre pregnancy screening is a feasible and effective approach to thalassemia prevention.

[1]  Chi-kong Li New trend in the epidemiology of thalassaemia. , 2017, Best practice & research. Clinical obstetrics & gynaecology.

[2]  D. Canatan,et al.  Report on Ten Years’ Experience of Premarital Hemoglobinopathy Screening at a Center in Antalya, Southern Turkey , 2016, Hemoglobin.

[3]  Dongzhi Li,et al.  Consequences of Delayed Prenatal Diagnosis of β-Thalassemia in Mainland China , 2016, Hemoglobin.

[4]  D. Rund Thalassemia 2016: Modern medicine battles an ancient disease , 2016, American journal of hematology.

[5]  Dongzhi Li,et al.  Prevention of Hb Bart’s (γ4) Disease Associated with the – –THAI α0-Thalassemia Deletion in Mainland China , 2015, Hemoglobin.

[6]  C. Liao,et al.  Implementation of Newborn Screening for Hemoglobin H Disease in Mainland China , 2015, Indian Journal of Hematology and Blood Transfusion.

[7]  C. Liao,et al.  Prenatal control of Hb Bart’s hydrops fetalis: a two-year experience at a mainland Chinese hospital , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[8]  Dongzhi Li,et al.  Prenatal Control of Hb Bart’s Disease in Mainland China: Can We Do Better? , 2014, Hemoglobin.

[9]  Shaoke Chen,et al.  Prevention and control of Hb Bart's disease in Guangxi Zhuang Autonomous Region, China. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[10]  C. Liao,et al.  Newborn Screening for Hb H Disease by Determination of Hb Bart’s Using the Sebia Capillary Electrophoresis System in Southern China , 2014, Hemoglobin.

[11]  Dongzhi Li,et al.  Birth of children with severe β‐thalassemia at a tertiary obstetric hospital: what are the reasons behind it? , 2013, Prenatal diagnosis.

[12]  P. Grisanti,et al.  Carrier screening for inherited haemoglobin disorders among secondary school students and young adults in Latium, Italy , 2013, Journal of Community Genetics.

[13]  P. Grisanti,et al.  Carrier screening for inherited haemoglobin disorders among secondary school students and young adults in Latium, Italy , 2013, Journal of Community Genetics.

[14]  C. Liao,et al.  Prenatal control of nondeletional α‐thalassemia: first experience in mainland China , 2013, Prenatal diagnosis.

[15]  Dongzhi Li,et al.  Newborn screening for α-thalassaemia by a capillary electrophoresis method , 2012, Journal of medical screening.

[16]  L. Wadsworth,et al.  In Utero Diagnosis and Management of a Fetus With Homozygous &agr;-Thalassemia in the Second Trimester: A Case Report and Literature Review , 2011, Journal of pediatric hematology/oncology.

[17]  E. Vichinsky,et al.  Heterogeneity of hemoglobin H disease in childhood. , 2011, The New England journal of medicine.

[18]  E. Angelucci Hematopoietic stem cell transplantation in thalassemia. , 2010, Hematology. American Society of Hematology. Education Program.

[19]  Maxine Sun,et al.  Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China , 2010, Clinical genetics.

[20]  Lin Peng,et al.  Hemoglobin H Disease in Guangxi Province, Southern China: Clinical Review of 357 Patients , 2010, Acta Haematologica.

[21]  Dongzhi Li Premarital screening for thalassemia in mainland China , 2009, Prenatal Diagnosis.

[22]  Matthew Darlison,et al.  Global epidemiology of haemoglobin disorders and derived service indicators. , 2008, Bulletin of the World Health Organization.

[23]  C. Liao,et al.  A case of transfusion‐dependent nondeletional Hb H disease undiagnosed during prenatal screening for thalassemia , 2008, Prenatal diagnosis.

[24]  Xiang-min Xu,et al.  Carrier screening for α‐ and β‐thalassemia in pregnancy: the results of an 11‐year prospective program in Guangzhou Maternal and Neonatal hospital , 2005 .

[25]  G. Luo,et al.  The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening , 2004, Journal of Clinical Pathology.

[26]  Y. Lau,et al.  Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? , 2001, Journal of clinical pathology.

[27]  V. Chan,et al.  Genetic and clinical features of hemoglobin H disease in Chinese patients. , 2000, The New England journal of medicine.

[28]  V. Chan,et al.  A reverse dot‐blot method for rapid detection of non‐deletion α thalassaemia , 1999 .

[29]  Qiang Zhang,et al.  Prenatal diagnosis of β-thalassemia in Guangxi Zhuang Autonomous Region, China , 2013, Archives of Gynecology and Obstetrics.

[30]  E. Vichinsky Alpha thalassemia major--new mutations, intrauterine management, and outcomes. , 2009, Hematology. American Society of Hematology. Education Program.

[31]  E. Ma,et al.  Interaction between (--SEA) alpha-thalassemia deletion and uncommon non-deletional alpha-globin gene mutations in Chinese patients. , 2001, Haematologica.